0001435049-11-000001.txt : 20110422
0001435049-11-000001.hdr.sgml : 20110422
20110421184642
ACCESSION NUMBER: 0001435049-11-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20110422
DATE AS OF CHANGE: 20110421
EFFECTIVENESS DATE: 20110422
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ADURO BIOTECH
CENTRAL INDEX KEY: 0001435049
IRS NUMBER: 000000000
STATE OF INCORPORATION: CA
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-158787
FILM NUMBER: 11774416
BUSINESS ADDRESS:
STREET 1: 626 BANCROFT WAY
STREET 2: SUITE 3-C
CITY: BERKELEY
STATE: CA
ZIP: 94710
BUSINESS PHONE: 510-848-4400
MAIL ADDRESS:
STREET 1: 626 BANCROFT WAY
STREET 2: SUITE 3-C
CITY: BERKELEY
STATE: CA
ZIP: 94710
D
1
primary_doc.xml
X0704
D
LIVE
0001435049
ADURO BIOTECH
626 BANCROFT WAY
SUITE 3-C
BERKELEY
CA
CALIFORNIA
94710
510-848-4400
CALIFORNIA
Oncologic Inc.
NanoTx Corp.
None
Corporation
true
Stephen
T.
Isaacs
626 Bancroft Way
Suite 3-C
Berkeley
CA
CALIFORNIA
94710
Executive Officer
Director
S.
David
Model
200 Turnpike Road
Chelmsford
MA
MASSACHUSETTS
01824
Executive Officer
Ross
Haghighat
200 Turnpike Road
Chelmsford
MA
MASSACHUSETTS
01824
Director
William
Greenman
626 Bancroft Way
Suite 3-C
Berkeley
CA
CALIFORNIA
94710
Director
Stephanie
O'Brien
626 Bancroft Way
Suite 3-C
Berkeley
CA
CALIFORNIA
94710
Director
Frank
McCormick
626 Bancroft Way
Suite 3-C
Berkeley
CA
CALIFORNIA
94710
Director
Biotechnology
Decline to Disclose
- 06
false
2011-04-15
false
true
true
false
0
19233346
2228674
17004672
false
9
0
0
0
true
Proceeds will be used for general corporate purposes.
false
ADURO BIOTECH
/s/ David Model
David Model
CFO
2011-04-21